• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEvommune
    Picture of Evommune logo

    EVMN — Evommune Share News

    $5.100.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      $185.04m
    • Enterprise Value
      -$14.80m
    • Revenue
      $13.00m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • EVMN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    EVMN Dividends
    • Brief: Evommune Inc On Feb 12, Enters Securities Purchase Agreement With Investors

      13/02/2026 13:07
    • U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart

      11/02/2026 08:12
    • Evommune soars after eczema therapy shows promise in mid-stage trial

      10/02/2026 16:00
    • Evommune soars after eczema therapy shows promise in mid-stage trial

      10/02/2026 13:52
    • Aktis Oncology files for US IPO as biotech listings rebound

      19/12/2025 22:45
    • Live Markets: S&P 500 wraps up biggest profit growth season since Q4 2024

      15/12/2025 18:29
    • Live Markets: Stephens tweaks view for 2026 Russell Recon

      15/12/2025 17:35
    • Evommune surges in NYSE debut after $150 million IPO

      06/11/2025 19:06
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.